EX-99.1 2 ex99-1.htm Exhibit 99.1 Molecular P Templates, Inc. DIP Financing Term Sheet a g e | 1 DIP FINANCING PROPOSAL for: April 20, 2025 ATTN: Craig Jalbert, President, Chief Executive Officer Molecular Templates, Inc. 9301 Amberglen Boulevard Suite 100 Austin, TX 78729 K2 HealthVentures LLC, 855 Boylston Street, 10 Floor, Boston, MA 02116 Molecular P Templates, Inc. DIP Financing Term Sheet a g e | 2 Dear Craig, Based on our discussions, we are pleased to present the following binding DIP Financing Term Sheet. Below is a summary of the terms for the financing (“ Term Sheet ”). THIS TERM SHEET SETS FORTH THE TERMS AND CONDITIONS UPON WHICH DIP LENDER SHALL, SUBJECT TO ENTRY OF THE FINANCING ORDERS (DEFINED BELOW), PROVIDE THE DIP LOANS (DEFINED BELOW) UNDER THE DIP FACILITY (DEFINED BELOW) TO THE DEBTOR (DEFINED BELOW). THIS TERM SHEET SHALL BE A BINDING AGREEMENT WITH RESPECT TO THE DIP LOANS AND THE DIP FACILITY SUBJECT TO THE DIP ORDERS AND, TOGETHER WITH THE DIP ORDERS AND ANY OTHER RELATED AGREEMENTS, SCHEDULES, EXHIBITS, SECURITY AGREEMENTS, PLEDGE AGREEMENTS OR OT…
Open exhibit ↗Current Report · Items 1.01, 1.03, 2.03, 2.04, 9.01 · 8-K
Molecular Templates, Inc.
Entry into a Material Definitive Agreement · Bankruptcy or Receivership · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Triggering Events That Accelerate or Increase a Direct Financial Obligation
Item 1.01. Entry into a Material Definitive Agreement The information set forth below in Item 1.03 of this Current Report on Form 8-K (this “Form 8-K”) is incorporated herein by reference.
Recent company filings
- 25-NSE - filed by Nasdaq Stock Market LLC regarding Molecular Templates, Inc.May 22, 2025
- Entry into a Material Definitive Agreement · Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement · Material Modification to Rights of Security HoldersFeb 26, 2025
- Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other EventsJan 2, 2025
- 8-K filingDec 19, 2024
- DEFA14A filingDec 4, 2024
Disclosure sections
Item 1.01Item 1.01 - Entry into Material Agreement
Item
1.01. Entry into a Material Definitive Agreement
The
information set forth below in Item 1.03 of this Current Report on Form 8-K (this “Form 8-K”) is incorporated herein by reference.
Item 1.03Item 1.03 - Bankruptcy or Receivership
Item
1.03 Bankruptcy or Receivership
Bankruptcy
Filing
On
April 20, 2025 (the “Petition Date”), Molecular Templates, Inc. (the “Company”) and its affiliate, Molecular
Templates OpCo, Inc. (“MTEM OpCo”, and together with the Company, the “Debtors”), commenced chapter 11 cases
(the “Chapter 11 Cases”) as debtors in possession in voluntary proceedings under Chapter 11
of the United States Code, 11 U.S.C. §§ 101-1532, as amended from time to time (the “Bankruptcy Code”) in the United
States Bankruptcy Court for the District of Delaware (the “Bankruptcy Court”). The case numbers for the Chapter 11 Cases
are: 25-10739 and 25-10740. The Company and its affiliate currently remain in possession of their respective assets and currently
continue to operate as “debtors in possession” under the jurisdiction of the Bankruptcy Court, and in accordance with the
applicable provisions of the Bankruptcy Code and the orders of the Bankruptcy Court.
Additional
information about the Chapter 11 Cases, including access to Bankruptcy Court documents, is available online at https://www.veritaglobal.net/moleculartemplates,
a website administered by Kurtzman Carson Consultants, LLC d/b/a Verita Global, a third-party bankruptcy claims and noticing agent. The
information on this website is not incorporated by reference into, and does not constitute part of, this Form 8-K.
Restructuring
Support Agreement Term Sheet
Subject
to Bankruptcy Court approval, the Company intends to effectuate a debt-for-equity transaction, pursuant to the confirmation of a plan
of reorganization, and in accordance with a restructuring support agreement term sheet entered into with K2 HealthVentures LLC (“K2”),
dated April 20, 2025 (together with all annexes attached thereto, the “RSA Term Sheet”). Material provisions of the RSA Term
Sheet include, among others: (i) the satisfaction of certain case milestones; (ii) the satisfaction and release of $15,000,000
of K2’s prepetition secured claims against the Company in exchange for 100% of newly issued common equity interests in the reorganized
company; (iii) the provision of customary releases (including third party releases) for key stakeholders, including the Company and K2,
to the maximum extent permitted under applicable law; and (iv) the cancellation, extinguishment, and discharge of all of the Company’s
existing common and preferred stock.
Postpetition
Debtor-in-Possession Financing
In
connection with the Chapter 11 Cases, the Debtors filed various “first day” motions seeking Bankruptcy Court approval. 1 At a hearing held on April 22, 2025, the Bankruptcy Court approved, among other things, the Company’s debtor-in-possession
financing on the terms set forth in a proposed Interim Order (I) Authorizing the Debtors to (A) Obtain Postpetition Financing
and (B) Utilize Cash Collateral, (II) Granting Adequate Protection to the Prepetition Lender, (III) Modifying the Automatic Stay, (IV)
Scheduling a Final Hearing, and (V) Granting Related Relief (the “Interim Order”) and the DIP
Term Sheet, dated April 20, 2025 (together with all exhibits and schedules thereto, the “DIP Term Sheet” and, together with
the Interim Order, the Final Order and the DIP Budget (each as defined in the Interim Order), and any other schedules, exhibits, agreements,
instruments, pledge agreements, guarantees, security agreements, intellectual property security agreements, control agreements, escrow
agreements, instruments, notes, and documents executed in accordance and connection with any of the foregoing; each as amended, restated,
supplemented, waived, or otherwise modified from time to time in accordance with the terms thereof, the “DIP Documents”)
with K2.
1 Copies of the “first day” motions and orders are available free of charge at www.veritaglobal.net/MolecularTemplates.
Copies of the first day motions and orders may also be inspected in the offices of the Clerk of the Bankruptcy Court during normal
business hours or downloaded from the Bankruptcy Court’s website at www.deb.uscourts.gov. Please note that prior registration
with the PACER Service Center and payment of a fee may be required to access such documents. Parties in interest may sign up for a
PACER account by visiting the PACER website at http://pacer.psc.uscourts.gov or by calling (800) 676-6856. The information on
such websites is not incorporated by reference into, and does not constitute part of, this Form 8-K.
The
Bankruptcy Court authorized the Company to obtain, on an interim basis, post-petition financing on a senior secured super-priority
basis (the “DIP Facility”) from K2, comprised of: (i) a new money term loan facility (the “New Money DIP Loans”)
in an aggregate maximum principal amount of $3,000,000, of which $500,000 will be available to the Company upon entry of the
Interim Order; and (ii) a roll-up (the “Roll-Up Loans” and together with the New Money DIP Loans, the “DIP Loans”)
of a portion of the outstanding obligations arising under: (i) that certain Amended and Restated Secured Contingent Value Right Agreement,
dated February 20, 2025 (the “A&R CVR”), and (ii) that certain Loan and Security Agreement, dated February 20, 2025 (the
“Bridge Loan”), equal to $6,000,000 pursuant to the Interim Order and an additional $3,000,000 (for a total of $9,000,000)
upon final approval of the DIP Facility. The DIP Facility is subject to the terms and conditions set forth in the Interim Order,
the DIP Budget, and the DIP Term Sheet. Subject to the DIP Documents, the DIP Facility is secured by first-priority, senior liens on
substantially all of the Debtor’s assets, subject only to certain permitted liens and a professional fee carve-out.
The
maturity date of the DIP Facility (the “Maturity Date”) shall be the earliest to occur of the following: (i) seventy (70)
days following the Petition Date; (ii) the acceleration or termination of the DIP Facility as a result of an Event of Default (as defined
below); or (iii) the effective date of a plan filed in the cases and confirmed by the Bankruptcy Court; provided that the Maturity Date
may be extended upon the written consent of the Administrative Agent in its sole and absolute discretion. Interest shall accrue on the
DIP Loans at the rate of 13.5% per annum, and shall accrue and be capitalized monthly on the first (1st) business day of each month and
added to the principal amount outstanding on such date. Interest shall accrue in kind and shall be paid in full in cash on the Maturity
Date or otherwise satisfied all or a portion thereof through a debt-for-equity conversion through a plan. Events of Default under
the DIP Term Sheet include, among others: (i) the use of proceeds from the DIP Facility, the DIP Collateral and the Cash Collateral (each
as defined in the Interim Order) not in accordance with the DIP Financing Term Sheet and the DIP Documents, (ii) the failure to meet
certain case milestones, subject to the availability of the Bankruptcy Court; (iii) and the filing of a pleading, plan, or document or
entry of an order that is inconsistent with the DIP Financing Term Sheet, the DIP Documents, or the RSA Term Sheet.
The
foregoing summary of the DIP Term Sheet does not purport to be complete and is subject to, and qualified in its entirety by, the full
text of the DIP Term Sheet, a copy of which is filed as Exhibit 99.1 to this current report on Form 8-K and is incorporated herein by
reference.
Item
2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The
information set forth above in Item 1.03 of this Form 8-K regarding the DIP Facility is hereby incorporated by reference in this Item
2.03.
Item 2.04.
Triggering Events that Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement.
The
information set forth above in Item 1.03 of this Form 8-K regarding the Chapter 11 Cases is incorporated herein by reference. The commencement
of the Chapter 11 Cases constitutes an “event of default” under the Bridge Loan and an “acceleration event” under
the CVR Agreement. The terms of the Bridge Loan provide that, as a result of the Chapter 11 Cases, the principal and interest thereunder
shall be immediately due and payable, and the terms of the CVR Agreement provide that, as a result of the Chapter 11 Cases, the
payments due thereunder shall be immediately due and payable. Any efforts to enforce the payment obligations under the Bridge Loan and
the CVR Agreement are automatically stayed as a result of the Chapter 11 Cases, and the creditors’ rights of enforcement are subject
to the Bankruptcy Code.
CAUTIONARY
NOTE REGARDING THE COMPANY’S SECURITIES
The
Company cautions that trading in the Company’s securities during the pendency of the Chapter 11 Cases is highly speculative and
poses substantial risks. Trading prices for the Company’s securities may bear little or no relationship to the actual recovery,
if any, by holders of the Company’s securities in the Chapter 11 Cases.
CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS
This
Form 8-K contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements
contained in this Form 8-K that do not relate to matters of historical fact should be considered forward-looking statements, including,
but not limited to, statements regarding the Company’s possession of its respective assets and operation of its respective business
as a “debtor in possession” under the jurisdiction of the Bankruptcy Court and the timeline for and execution of its plan
confirmation process. The Company’s actual results and the timing of events could differ materially from those anticipated in such
forward-looking statements as a result of important risks and uncertainties, including without limitation, risks associated with the
Company’s ability to comply with its obligations under the DIP Facility, among other important risks and uncertainties. A further
description of the risks and uncertainties relating to the business of the Company is contained in the Company’s most recent annual
report on Form 10-K and the Company’s quarterly reports on Form 10-Q filed with the Securities and Exchange Commission. The Company
undertakes no duty or obligation to update any forward-looking statements contained in this report as a result of new information, future
events or changes in its expectations.
Item 9.01.
Financial Statements and Exhibits.
(d)
Exhibits
Exhibit Description
No.
──────────────────────────────────────────────────────────────────────────────────────
99.1 DIP Term Sheet
104 Cover
Page Interactive Data File (embedded within the Inline XBRL document)